Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Martin Kåberg, Simon B. Larsson, Anna Jerkeman, Anders Nystedt, Ann-Sofi Duberg, Jan Kövamees, Magdalena Ydreborg, Soo Aleman, Katharina Büsch, Marianne Alanko Blomé, Ola Weiland & Jonas Söderholm. (2020) High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder. Scandinavian Journal of Gastroenterology 55:5, pages 574-580.
Read now
Read now
Articles from other publishers (5)
Christopher J Byrne, Andrew Radley, Emma Fletcher, Donna Thain, Brian P Stephens & John F Dillon. (2023) A multicomponent holistic care pathway for people who use drugs in Tayside, Scotland. International Journal of Drug Policy 120, pages 104159.
Crossref
Crossref
K. Lindqvist, Z. Thorin & M. Kåberg. (2023) Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden. Harm Reduction Journal 20:1.
Crossref
Crossref
Sona Frankova, Nikola Uzlova, Dusan Merta, Veronika Pitova & Jan Sperl. (2023) Predictors of Significant Liver Fibrosis in People with Chronic Hepatitis C Who Inject Drugs in the Czech Republic. Life 13:4, pages 932.
Crossref
Crossref
Paul N. Brennan, Christopher J. Byrne & John F. Dillon. (2022) Decentralisation of hepatitis C virus care into community settings: A key approach on the path to elimination. Liver International 42:6, pages 1222-1224.
Crossref
Crossref
Brennan Paul Noel, Cartlidge Peter, Robinson Emma, Amarthingalam Asthika & Dillon John Francis. (2022) Cohort study: Apparent redundancy of fibrosis assessment in young persons with HCV; development of realistic approaches to break the paradigm. Annals of Hepatology 27:1, pages 100550.
Crossref
Crossref